GCP
GRTX

GSA Capital Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

GSA Capital Partners’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,632,627
Closed -$509K – 2127
2024
Q1 		$509K Sell
3,632,627
-259,934
-7% -$51.2K 0.04% 875
2023
Q4 		$566K Buy
+3,892,561
New +$605K 0.05% 719

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

GSA Capital Partners's GRTX Position: Q2 2024 in Review

GSA Capital Partners sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 3,632,627 shares — an estimated $509K sold.

GSA Capital Partners first reported a position in GRTX in Q4 2023 and held it in 2 quarters. The position peaked at $566K in Q4 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • GSA Capital Partners reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • GSA Capital Partners sold 3,632,627 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $509K.
  • GSA Capital Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • GSA Capital Partners's Galera Therapeutics, Inc. Common Stock position peaked at $566K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.